Therapeutic Potential of <scp>3D</scp> ‐Printed Nifurtimox for Chagas Disease: Effects on Survival, Parasitemia Control and Immune Modulation
3D nifurtimox represents a promising new version of nifurtimox capable of being used in low doses with comparable or superior effects to benznidazole (100 mg/kg) and can be considered a promising tool for anti-T. cruzi therapies.
Authors
- Claudio J. Salomón (ORCID: https://orcid.org/0000-0003-1599-790X)
- Ana Luiza Lima (ORCID: https://orcid.org/0000-0002-2177-8941)
- Idejan Padilha Gross (ORCID: https://orcid.org/0000-0002-1798-7927)
- André Talvani (ORCID: https://orcid.org/0000-0002-6685-6229)
- Vitória Louise
- Bianca Alves Almeida Machado
- Giselle Bedogni (ORCID: https://orcid.org/0009-0007-2020-1466)
- Sirlaine Pio (ORCID: https://orcid.org/0000-0001-9356-7898)
- Daniel Malta Oliveira
- Tatiana Prata Menezes
- Débora Maria Soares Souza
- Marcilio Cunha‐Filho
Institutions
- Universidade Federal de Ouro Preto (BR)
- Universidade Federal de Minas Gerais (BR)
- Universidade de Brasília (BR)
- National University of Rosario (AR)
Publication Details
- Journal
- Tropical Medicine & International Health
- Published
- 2026-01-25
- DOI
- https://doi.org/10.1111/tmi.70085
- Primary Topic
- Trypanosoma species research and implications
- Type
- article
- Field-Weighted Citation Impact
- 0.00